Published in Br J Haematol on February 01, 1974
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med (1973) 3.21
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Quantitative reflection contrast microscopy of living cells. J Cell Biol (1979) 2.22
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol (2001) 1.94
Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol (1996) 1.78
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. Cancer Res (1974) 1.68
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma. Eur J Haematol (2000) 1.46
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
Lymphoma and systemic sclerosis--an uncommon association or possible coincidence of two disorders with a fatal outcome. Eur J Haematol (1997) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study. Leuk Res (2011) 1.40
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Value of lymphangiography in the staging of Hodgkin lymphoma. Radiology (1994) 1.38
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett (2001) 1.29
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Immunofluorescent demonstration of enteropathogenic Escherichia coli in tissues of infants dying with enteritis. Pediatrics (1970) 1.25
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Pulmonary involvement in lymphoma. Leuk Lymphoma (1996) 1.23
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol (2013) 1.23
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. Comput Biomed Res (1976) 1.21
Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol (1979) 1.19
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia (2001) 1.16
Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative disease. Am J Med (1976) 1.15
Scanning electron microscopy of murine macrophages. Surface characteristics during maturation, activation, and phagocytosis. Lab Invest (1975) 1.14
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol (2005) 1.12
The liver in amyloidosis. Digestion (1974) 1.11
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Intercellular communication in pancreatic islet monolayer cultures: a microfluorometric study. Science (1979) 1.09
Microspectrophotometry of single rhabdomeres in the insect eye. Exp Cell Res (1966) 1.08
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Cancer Res (1982) 1.08
CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. Clin Radiol (2003) 1.07
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol (1981) 1.03
Potentiating effect of vitamin A on 9-10 dimethyl 1-2 benzanthracene--carcinogenesis in the hamster cheek pouch. Cancer (1968) 1.03
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. Ann Oncol (2011) 1.00
Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res (1993) 1.00
Microspectrofluorometric approach to the study of free/bound NAD(P)H ratio as metabolic indicator in various cell types. Photochem Photobiol (1982) 1.00
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood (1978) 1.00
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. Br J Cancer (1998) 0.99
Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features. J Exp Med (1980) 0.99
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol (2010) 0.99
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med (1976) 0.98
Scanning electron microscopy of human lymphocyte-sheep erythrocyte rosettes. J Exp Med (1974) 0.98
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol (1976) 0.98
Inhibition of chemical carcinogenesis in the hamster cheek pouch by topical chlorpromazine. Nature (1970) 0.98
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood (1992) 0.98
The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells (1993) 0.97
Sudden onset deafness as a presenting manifestation of chronic lymphocytic leukemia. Leuk Lymphoma (1993) 0.97
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg (1982) 0.96
Development of plasma cell tumors during treatment of multiple myeloma. Ann Hematol (1996) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia. Leuk Lymphoma (1992) 0.96
Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer (1984) 0.95
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol (1978) 0.94
CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma. Eur Radiol (2000) 0.94
Studies on metabolic events in localized compartments of the living cell by rapid microspectrofluorometry. Adv Biol Med Phys (1974) 0.94
Widespread Castleman disease: CT and US findings. Radiology (1988) 0.94
Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis (1991) 0.94
Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet (1978) 0.94
Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am J Hematol (1980) 0.93
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. Ann Oncol (2009) 0.93
Plasmacytoma of the breast. Unusual initial presentation of myeloma: report of two cases and review of the literature. Blut (1989) 0.93
The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer (2000) 0.93
Cancer patterns in the Middle East--special report from the Middle East Cancer Society. Acta Oncol (1997) 0.93
The effect of topical vitamin A on papillomas and intraepithelial carcinomas induced in hamster cheek pouches with 9,10-dimethyl-1,2-benzanthracene. Cancer Res (1969) 0.93
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
Enhancing effect of excess topical vitamin A on Rous sarcomas in chickens. J Natl Cancer Inst (1972) 0.92
Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A (1992) 0.92
ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood (1999) 0.92
Surface morphology of murine B and T lymphocytes: A comparative study by scanning electron microscopy. Eur J Immunol (1975) 0.92
Extramedullary hematopoietic tumors of the cranial dura mater. Acta Haematol (1969) 0.92
Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol (1997) 0.91
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest (1989) 0.91
Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol (1979) 0.91